[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Schwartz et al., 2022 - Google Patents

Innate PD-L1 limits T cell–mediated adipose tissue inflammation and ameliorates diet-induced obesity

Schwartz et al., 2022

View PDF
Document ID
11603819439795750799
Author
Schwartz C
Schmidt V
Deinzer A
Hawerkamp H
Hams E
Bayerlein J
Röger O
Bailer M
Krautz C
El Gendy A
Elshafei M
Heneghan H
Hogan A
O’Shea D
Fallon P
Publication year
Publication venue
Science translational medicine

External Links

Snippet

Obesity has become a major health problem in the industrialized world. Immune regulation plays an important role in adipose tissue homeostasis; however, the initial events that shift the balance from a noninflammatory homeostatic environment toward inflammation leading …
Continue reading at drive.google.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Schwartz et al. Innate PD-L1 limits T cell–mediated adipose tissue inflammation and ameliorates diet-induced obesity
Ng et al. RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice
Lucca et al. Modulation of regulatory T cell function and stability by co-inhibitory receptors
Tu et al. T cell receptor-regulated TGF-β type I receptor expression determines T cell quiescence and activation
Sharabi et al. Regulatory T cells in the treatment of disease
Lückel et al. IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis
Jung et al. CRISPR/Cas9-mediated knockout of DGK improves antitumor activities of human T cells
Longman et al. CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22
Zhang et al. A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
Williams et al. The EGR2 targets LAG-3 and 4-1BB describe and regulate dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment
Robb et al. Identification and expansion of highly suppressive CD8+ FoxP3+ regulatory T cells after experimental allogeneic bone marrow transplantation
Chen et al. Deficiency of complement C3a and C5a receptors prevents angiotensin II–induced hypertension via regulatory T cells
Selck et al. Antigen-specific regulatory T cell therapy in autoimmune diseases and transplantation
Raeber et al. Interleukin-2 signals converge in a lymphoid–dendritic cell pathway that promotes anticancer immunity
Dalmas et al. T cell–derived IL-22 amplifies IL-1β–driven inflammation in human adipose tissue: Relevance to obesity and type 2 diabetes
Batten et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells
Jin et al. Keratin 17: a critical player in the pathogenesis of psoriasis
Caza et al. Functional and phenotypic plasticity of CD4+ T cell subsets
Remedios et al. The TNFRSF members CD27 and OX40 coordinately limit TH17 differentiation in regulatory T cells
Jäger et al. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes
Price et al. DCIR2+ cDC2 DCs and Zbtb32 restore CD4+ T-cell tolerance and inhibit diabetes
Redmond et al. Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression
Li et al. SLAMF3 and SLAMF4 are immune checkpoints that constrain macrophage phagocytosis of hematopoietic tumors
Zhang et al. mTOR limits the recruitment of CD11b+ Gr1+ Ly6Chigh myeloid-derived suppressor cells in protecting against murine immunological hepatic injury
Chng et al. Adaptive immunity and antigen‐specific activation in obesity‐associated insulin resistance